fda glp-1 compounding warning october 2025 warns 30 telehealth firms over illegal sales New project announcement: HHS‑OIG is

Multiple studies reviewed in this article document the diverse effects of these drugs on the glucagon-like peptide-1 receptors that are widely expressed in the human body, including the nervous system modulating appetite, the gastrointestinal tract modifying gastric emptying, and lipid metabolism regulation leading to reduction in fat deposition

Wiley: 513

Unfortunately, this trial did not pass Phase I with five of the seven enrolled patients experiencing serious adverse effects, including supraventricular tachycardia, convulsion, and pulmonary embolism

Fat may be driven to the abdomen, chest, upper back (referred to as a "buffalo hump") or face, sometimes considered "moon face," the doctor said